Sign In

Friday, May 04, 2018 - 8:00 am to Saturday, May 05, 2018 - 12:30 pm

Course Description / Need Statement

The goal of the Clinical Hepatology Update Conference was to give medical professionals the opportunity to learn about up-to-date diagnosis and management of a variety of liver diseases with experts and leaders in the field of hepatology. The conference covered ongoing research in a variety of liver related topics with the potential of having significant impact on the future practice of Clinical Hepatology.

Program Chairs

  • Hari S. Conjeevaram, MD, MS
  • Coleman I. Smith, MD, FAASLD
  • Elizabeth K. Goacher, PA-C, MHS
  • April G. Morris, FNP

Continuing Education

  • CME – 12.25 AMA PRA Category 1 Credits™
  • ABIM MOC – 12.25 Points
  • ABP MOC – 12.00 Points
  • CE: 12.25 Contact Hours
  • Pharmacology Education: 4.00 Pharmacology Credits

Registration Pricing Early Bird: On or Before April 4

  • Member $325
  • Trainee & Assoc. Members $185
  • Non-Member $540
  • Any physician, scientist, or researcher with doctoral-level training
    who is not employed by Industry (pharma/device/etc.)
  • Trainee & Assoc. Non-Member $235
    Any physician, scientist or researcher in a training program as certified
    by the director of their training program. This category also includes, but is not limited to, the degrees of
    MS, NP, PA, RN, and other related or comparable degrees.
  • Industry $775
    Any Industry (pharma/device/etc.) employee with or without medical training.

*Requests for cancellations must be submitted in writing to meetings@aasld.org. Cancellations received: on or before April 4 will be refunded in full. Refunds between April 5 and April 18 will be subject to a $50.00 cancellation fee. Cancellations on or after April 19 are not eligible for a refund.

Registration Pricing: On or After April 5

  • Member $425
  • Trainee & Assoc. Members $210
  • Non-Member $640
  • Any physician, scientist, or researcher with doctoral-level training
    who is not employed by Industry (pharma/device/etc.)
  • Trainee & Assoc. Non-Member $260
    Any physician, scientist or researcher in a training program as certified
    by the director of their training program. This category also includes, but is not limited to, the degrees of
    MS, NP, PA, RN, and other related or comparable degrees.
  • Industry $875
    Any Industry (pharma/device/etc.) employee with or without medical training.

*Requests for cancellations must be submitted in writing to meetings@aasld.org. Cancellations received: on or before April 4 will be refunded in full. Refunds between April 5 and April 18 will be subject to a $50.00 cancellation fee. Cancellations on or after April 19 are not eligible for a refund.

Session I: Common Hepatology Consults

Friday, May 4, 2018
Moderators: Hari Conjeevaram, MD, MS and Zobair M. Younossi, MD, MPH, FAASLD

  • 7 am
    Breakfast
  • 8–8:10 am
    Introduction
    Hari Conjeevaram, MD, MS and Elizabeth Goacher, PA-C, MHS
  • 8:10–8:30 am
    Diagnosis and Management of Suspected DILI
    Robert J. Fontana, MD, FAASLD
  • 8:30-8:50 am
    Can My Patient Take...?: The Liver on Drugs and Drugs in the Liver
    Victor J. Navarro, MD, FAASLD
  • 8:50–9:10 am
    Can My Patient Go to the OR and at What Risk? Surgical Risk Assessment and Perioperative Management Recommendations for Cirrhotic Patients Undergoing Cholecystectomy, CABG, and Joint Replacement
    Lindsay King, MD
  • 9:10–9:30 am
    Acute Liver Failure: When Should the Patient be Transferred to a Transplant Center?
    Amol S. Rangnekar, MD
  • 9:30–10 am
    Q&A
  • 10–10:20 am
    Break

Session II: Beyond the Liver

Friday, May 4, 2018
Moderators: Jessica Mellinger, MD and Coleman I. Smith, MD, FAASLD

  • 10:20–10:40 am
    Pulmonary Complications of Liver Disease
    Michael B. Fallon, MD, FAASLD
  • 10:40–11 am
    The Liver and the Kidney
    Amol S. Rangnekar, MD
  • 11–11:20 am
    Anticoagulation in Patients with Cirrhosis
    Stephen H. Caldwell, MD, FAASLD
  • 11:20–11:40 am
    The Role of Muscle Mass and Frailty in Liver Disease and What to Do About It
    Elliott B.Tapper, MD
  • 11:40–Noon
    Liver Disease and Nutrition in 2018
    Matthew R. Kappus, MD
  • Noon–12:30 pm
    Q&A
  • 12:30–1:50 pm
    Breakout Sessions: 
    Prevention of Re-Hospitalizations in Patients with Decompensated Cirrhosis
    Moderators: Elizabeth K. Goacher, PA-C, MHS and Elliott B.Tapper, MD

    Preventative Health Care Strategies in Cirrhosis
    Moderators: April G. Morris, FNP and  Jessica Mellinger, MD

Session III: NAFLD

Friday, May 4, 2018 
Moderators: Stephen H. Caldwell, MD, FAASLD and Matthew R. Kappus, MD

  • 2–2:20 pm
    Natural History of NAFLD
    Zobair M. Younossi, MD, MPH, FAASLD
  • 2:20 pm–2:40 pm
    How Do I Manage My NAFLD Patient?: What is Available Now and in the Future
    Cynthia Moylan, MD
  • 2:40–3 pm
    The Hepatologist as Endocrinologist and Cardiologist: Addressing Hyperlipidemia, Diabetes and Cardiac Disease
    Hari Conjeevaram, MD, MS
  • 3–3:20 pm
    Q&A
  • 3:20–3:40 pm
    Break
     

Session IV: Liver Masses

Friday, May 4, 2018
Moderators: Amol Rangnekar, MD and Lindsay King, MD

  • 3:40–4 pm
    Diagnostic Features of Commonly Encountered Liver Masses or What is this Incidentaloma?
    Mishal Mendiratta-Lala, MD
  • 4–4:20 pm
    Management of Benign Liver Lesions
    Coleman I. Smith, MD, FAASLD
  • 4:20–4:40 pm
    Hepatocellular Carcinoma Therapy Updates
    Catherine Frenette, MD
  • 4:40–5 pm
    Q&A

Session V: Miscellaneous Topics

Saturday, May 5, 2018
Moderators: Norah Terrault, MD, PhD and Michael B. Fallon, MD, FAASLD

  • 7 am
    Breakfast
  • 8–8:20 am
    Alcohol Before It Affects the Liver: Diagnosis, Trends, and Treatment in Alcohol-Associated Liver Disease
    Jessica Mellinger, MD
  • 8:20–8:40 am
    How to Assess and Manage Portal Hypertension and its Complications
    Puneeta Tandon, MD, FRCPC
  • 8:40–9 am
    Fibrosis Assessment Options: The Good, The Not So Good and the Worthless
    Mitchell L. Shiffman, MD, FAASLD
  • 9–9:20 am
    The Adult Survivor of Pediatric Liver Disease
    Nancy Reau, MD, FAASLD
  • 9:20–9:40 am
    Gut Microbiome in Liver Disease
    Hari Conjeevaram, MD, MS
  • 9:40–10:10 am
    Q&A
  • 10:10–10:30 am
    Break

Session VI: Viral Hepatitis

Saturday, May 5, 2018
Moderators: Elizabeth K. Goacher, PA-C, MHS and Nancy Reau, MD, FAASLD

  • 10:30–10:50 am
    Treatment of Unique Groups of Patients in the Era of DAAs
    Coleman I. Smith, MD, FAASLD
  • 10:50–11:10 am
    HBV Reactiviation with Immunotherapy
    Robert J. Fontana, MD, FAASLD
  • 11:10–11:30 am
    Hepatitis B: Is it Curable?
    Norah Terrault, MD, PhD
  • 11:30–Noon
    Q&A
  • Noon–12:30 pm
    Conference Summary and Wrap-Up
    Coleman I. Smith, MD, FAASLD and April Morris, FNP
  • 12:30 pm
    Adjourn